FealtySign in

Philip Morris International Inc.

(PM)

CIK 1413329 · SEC filings only

Not gradedDividend record
shown as history
company entity
67 dividend record entries

Dividend record — shown as history, not graded

A declared dividend is a reported fact, not a promise we grade. Here's the record — raises, holds, and cuts — each linked to its source filing.

Dividend record

67 declarations · 18 raised · 48 held · 0 cut · held 66 quarters

  1. HELD$1.4700/shperiod ended 2026-06-30Filing ↗
  2. HELD$1.4700/shperiod ended 2026-03-31Filing ↗
  3. RAISED$1.4700/shperiod ended 2025-09-30Filing ↗
  4. HELD$1.3500/shperiod ended 2025-06-30Filing ↗
  5. HELD$1.3500/shperiod ended 2025-03-31Filing ↗
  6. RAISED$1.3500/shperiod ended 2024-09-30Filing ↗
  7. HELD$1.3000/shperiod ended 2024-06-30Filing ↗
  8. HELD$1.3000/shperiod ended 2024-03-31Filing ↗
  9. RAISED$1.3000/shperiod ended 2023-09-30Filing ↗
  10. HELD$1.2700/shperiod ended 2023-06-30Filing ↗
  11. HELD$1.2700/shperiod ended 2023-03-31Filing ↗
  12. RAISED$1.2700/shperiod ended 2022-09-30Filing ↗
Descriptive dividend record — every entry links to its source filing. Not graded (a declared dividend is a reported fact, not a promise). Full methodology →
Not yet gradedBuyback record
harness minimum not met
company entity
1 resolved promise

Not enough resolved promises to grade

1 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.

See Pro →

Open promises (6)

Open · buyback authorization

No share repurchases

unresolved — no outcome on filereceipt →
Open · buyback authorization

our target of between $5 to $7 billion over 3 years

unresolved — no outcome on file$7.00Breceipt →
Open · buyback authorization

No share repurchases in 2024

unresolved — no outcome on file$0.0000receipt →
Open · buyback authorization

No share repurchases in 2024

unresolved — no outcome on file$0.0000receipt →
Open · buyback authorization

No share repurchases in 2024

next filing due$0.0000receipt →
Open · buyback authorization

No share repurchases

resolves in ~586 daysreceipt →

Credibility timeline

MISSED · Oct 26, 2023
20232023
Timeline as a list
  • Oct 26, 2023MISSEDwe target $5 billion to $7 billion
1 resolved buyback promise · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →
Not yet gradedGuidance record
harness minimum not met
company entity
3 resolved promises

Not enough GAAP-comparable guidance to grade

3 of the 4 resolved guidance promises needed to publish a reliability grade. Much of this company’s guidance is non-GAAP, which has no comparable GAAP actual in SEC XBRL to check it against — shown below, never scored. Here's what we're tracking — we never show a grade we can't back with receipts.

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance shown, not graded (76)

These are non-GAAP forecasts. There is no comparable GAAP figure in SEC XBRL to check them against, so we show what was said — with its source filing — but never score it.

  1. revenue guidance fy · Jul 22, 2026
    Net revenue growth of 5% to 7% on an organic basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. eps guidance fy · Jul 22, 2026
    Reported diluted EPS is forecast to be in a range of $7.19 to $7.34
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. eps guidance q · Jul 22, 2026
    Third quarter adjusted diluted EPS of $2.20 to $2.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  4. eps guidance fy · Apr 22, 2026
    Reported diluted EPS is forecast to be in a range of $7.56 to $7.71
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. eps guidance q · Apr 22, 2026
    Second quarter adjusted diluted EPS of $2.02 to $2.07
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  6. revenue guidance fy · Apr 22, 2026
    Net revenue growth of 5% to 7% on an organic basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. eps guidance fy · Feb 6, 2026
    9% to 11% for adjusted diluted EPS, excluding currency
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  8. eps guidance q · Feb 6, 2026
    First quarter adjusted diluted EPS of $1.80 to $1.85
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. revenue guidance fy · Feb 6, 2026
    Net revenue growth of 5% to 7% on an organic basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. eps guidance fy · Oct 21, 2025
    Reported diluted EPS is forecast to be in a range of $7.39 to $7.49
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  11. revenue guidance fy · Oct 21, 2025
    Net revenue growth of around 6% to 8% on an organic basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. eps guidance fy · Oct 21, 2025
    this forecast represents a projected increase of 12.0% to 13.5% versus adjusted diluted EPS of $6.57 in 2024
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  13. eps guidance fy · Jul 22, 2025
    Reported diluted EPS is forecast to be in a range of $7.24 to $7.37
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  14. eps guidance q · Jul 22, 2025
    Third quarter adjusted diluted EPS of $2.08 to $2.13
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  15. eps guidance fy · Jul 22, 2025
    Adjusted Diluted EPS, excluding currency $7.33 - $7.46
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. eps guidance fy · Apr 23, 2025
    Adjusted Diluted EPS, excluding currency $7.26 - $7.39
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  17. eps guidance fy · Apr 23, 2025
    Reported diluted EPS is forecast to be in a range of $7.01 to $7.14
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. eps guidance q · Apr 23, 2025
    Second quarter adjusted diluted EPS of $1.80 to $1.85
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. revenue guidance fy · Apr 23, 2025
    Net revenue growth of around 6% to 8% on an organic basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. revenue guidance fy · Feb 6, 2025
    Net revenue growth of around 6% to 8% on an organic basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. eps guidance fy · Feb 6, 2025
    Reported diluted EPS is forecast to be in a range of $6.55 to $6.68
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  22. eps guidance q · Feb 6, 2025
    First quarter adjusted diluted EPS of $1.58 to $1.63
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  23. eps guidance fy · Oct 22, 2024
    Reported diluted EPS is forecast to be in a range of $6.20 to $6.26
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  24. eps guidance fy · Oct 22, 2024
    raising our full-year growth outlook for adjusted diluted EPS to a range of 14% to 15%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  25. eps guidance fy · Jul 23, 2024
    Reported diluted EPS is forecast to be in a range of $5.89 to $6.01
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  26. eps guidance q · Jul 23, 2024
    third quarter adjusted diluted EPS of $1.77 to $1.82
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  27. revenue guidance fy · Apr 23, 2024
    Net revenue growth of 7% to 8.5% on an organic basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  28. eps guidance q · Apr 23, 2024
    second quarter adjusted diluted EPS of $1.50 to $1.55
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  29. eps guidance fy · Apr 23, 2024
    Reported diluted EPS is forecast to be in a range of $5.70 to $5.82
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  30. eps guidance fy · Feb 8, 2024
    Reported diluted EPS is forecast to be in a range of $5.90 to $6.02
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  31. eps guidance fy · Feb 8, 2024
    Adjusted Diluted EPS, excluding currency $6.43 - $6.55
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  32. eps guidance q · Feb 8, 2024
    first quarter adjusted diluted EPS of $1.37 to $1.42
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  33. revenue guidance fy · Feb 8, 2024
    Net revenue growth of 6.5% to 8% on an organic basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  34. eps guidance fy · Oct 19, 2023
    Reported diluted EPS is forecast to be in a range of $4.95 to $4.98
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  35. eps guidance fy · Oct 19, 2023
    TARGETS 2023 FULL-YEAR REPORTED DILUTED EPS OF $4.95 TO $4.98 AND ADJUSTED DILUTED EPS OF $6.05 TO $6.08
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  36. eps guidance q · Jul 20, 2023
    Third-quarter adjusted diluted EPS in a range of $1.60 to $1.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  37. eps guidance fy · Jul 20, 2023
    TARGETS 2023 FULL-YEAR REPORTED DILUTED EPS OF $5.36 TO $5.45
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  38. eps guidance fy · Jul 20, 2023
    ADJUSTED DILUTED EPS OF $6.13 TO $6.22
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  39. eps guidance fy · Apr 20, 2023
    currency-neutral adjusted diluted EPS growth of 7% to 9%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  40. eps guidance fy · Apr 20, 2023
    Reported diluted EPS is forecast to be in a range of $5.88 to $6.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  41. revenue guidance fy · Apr 20, 2023
    reaffirming our full-year 2023 forecast for organic net revenue growth of 7% to 8.5%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  42. eps guidance fy · Apr 20, 2023
    ADJUSTED DILUTED EPS OF $6.10 TO $6.22
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  43. eps guidance q · Apr 20, 2023
    Second-quarter adjusted diluted EPS in a range of $1.42 to $1.47
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  44. revenue guidance fy · Feb 9, 2023
    we forecast organic top-line growth of 7% to 8.5%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  45. eps guidance fy · Feb 9, 2023
    currency-neutral adjusted diluted EPS growth of 7% to 9%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  46. eps guidance q · Feb 9, 2023
    First-quarter reported diluted EPS in a range of $1.28 to $1.33
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  47. eps guidance fy · Oct 20, 2022
    expect full-year pro forma adjusted diluted EPS growth of 10% to 12%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  48. eps guidance fy · Jul 21, 2022
    diluted EPS of 10% to 12%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  49. eps guidance fy · Jul 21, 2022
    TARGETS 2022 FULL-YEAR REPORTED DILUTED EPS OF $5.73 TO $5.88
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  50. revenue guidance fy · Jul 21, 2022
    now expect to deliver pro forma adjusted growth in net revenues of 6% to 8%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  51. eps guidance q · Jul 21, 2022
    Pro forma third-quarter adjusted diluted EPS of $1.23 to $1.28
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  52. eps guidance q · Apr 21, 2022
    Pro forma second-quarter adjusted diluted EPS of $1.19 to $1.24
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  53. eps guidance fy · Apr 21, 2022
    PRO FORMA (EXCLUDING RUSSIA AND UKRAINE FOR ENTIRE 2022) ADJUSTED DILUTED EPS OF $5.35 TO $5.46
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  54. eps guidance fy · Apr 21, 2022
    full-year adjusted diluted EPS growth of 9% to 11%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  55. eps guidance fy · Apr 21, 2022
    TARGETS 2022 FULL-YEAR REPORTED DILUTED EPS* OF $5.39 TO $5.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  56. eps guidance q · Feb 10, 2022
    we expect adjusted diluted EPS of $1.50 to $1.55
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  57. eps guidance fy · Feb 10, 2022
    This translates into an adjusted diluted EPS range of $6.12-$6.30
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  58. revenue guidance fy · Jul 20, 2021
    we are revising our organic growth forecast to between +6% and +7%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  59. eps guidance q · Jul 20, 2021
    we expect EPS of $1.50 to $1.55
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  60. eps guidance fy · Jul 20, 2021
    raising our organic adjusted diluted EPS growth range to +12% to +14%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  61. eps guidance fy · Jul 20, 2021
    translates into an increased adjusted diluted EPS range of $5.97 to $6.07
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  62. eps guidance q · Apr 20, 2021
    we now expect adjusted diluted EPS of $1.50 to $1.55
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  63. eps guidance fy · Apr 20, 2021
    translates into a raised adjusted diluted EPS range of $5.95 to $6.05
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  64. revenue guidance fy · Apr 20, 2021
    We now expect organic net revenue growth in the range of 5% to 7%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  65. eps guidance q · Feb 4, 2021
    organic adjusted diluted EPS growth of around 8%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  66. eps guidance fy · Feb 4, 2021
    or 14% to 16% in dollar terms
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  67. eps guidance fy · Feb 4, 2021
    adjusted diluted EPS range of $5.90 to $6.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  68. eps guidance q · Feb 4, 2021
    equates to around $1.40
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  69. eps guidance fy · Feb 4, 2021
    organic adjusted diluted EPS growth of 9% to 11%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  70. eps guidance fy · Oct 20, 2020
    anticipate adjusted diluted EPS growth of around 5% to 6% on an organic basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  71. eps guidance fy · Oct 20, 2020
    RAISES 2020 FULL-YEAR REPORTED DILUTED EPS FORECAST TO A RANGE OF $5.03 TO $5.08
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  72. eps guidance q · Oct 20, 2020
    Fourth-quarter reported diluted EPS of around $1.16
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  73. eps guidance fy · Oct 20, 2020
    OR $5.05 TO $5.10 ON AN ADJUSTED BASIS
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  74. eps guidance fy · Jul 21, 2020
    PROVIDES 2020 FULL-YEAR REPORTED DILUTED EPS FORECAST OF $4.84 TO $4.99
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  75. eps guidance fy · Jul 21, 2020
    ADJUSTED DILUTED EPS OF $4.92 TO $5.07
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  76. eps guidance q · Apr 21, 2020
    PMI forecasts second-quarter reported diluted EPS to be in a range of $1.00 to $1.10
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗

Credibility timeline

WITHDRAWN · Apr 21, 2020WITHDRAWN · Jul 21, 2020MISSED · Feb 10, 2023BEAT · Feb 8, 2024KEPT · Feb 6, 2025
20202025
Timeline as a list
  • Apr 21, 2020WITHDRAWNwithdrawing our 2020 reported diluted EPS guidance of at least $5.50
  • Jul 21, 2020WITHDRAWNPMI withdrew its 2020 full-year reported diluted EPS forecast of at least $5.50
  • Feb 10, 2023MISSEDWe expect to deliver between 4% and 6% organic net revenue growth
  • Feb 8, 2024BEATraising our full-year 2023 forecast for organic net revenue growth to a range of 7.5% to 8.5%
  • Feb 6, 2025KEPTNet revenue growth of 7.5% to 9% on an organic basis
3 resolved guidance promises · 76dropped (couldn't be resolved on a consistent basis) · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →